〔９３１１〕第二类抗癌新药米托蒽醌的研制成果完成单位华西医科大学药学院华西医科大学附一院主研人员胥佩菱，何菱，伍朝，屈柄之，谢铭英主持鉴定单位四川省卫生厅鉴定日期１９９３年４月成果简介盐酸米托蒽醌注射液系国内首创，用于治疗白血病，乳癌、淋巴瘤、肺癌等... [9311] The second type of anti-cancer drug mitoxantrone research results completed unit Huaxi Medical University Huaxi Medical University, a hospital attached to the main research staff Xu Peiling, He Ling, Wu Chao, Qu Shazhi, Xie Mingying presided over the authentication unit Sichuan Province Department of Health Date of identification in April 1993 Results brief introduction Mitoxantrone injection is the first domestic initiative for the treatment of leukemia, breast cancer, lymphoma, lung cancer and so on.